- 专利标题： NOVEL SUBSTITUTED TRICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS
-
申请号： US18280175申请日： 2022-03-01
-
公开(公告)号： US20240109891A1公开(公告)日： 2024-04-04
- 发明人: Hongjian ZHANG , Jingjing JI , Peihua SUN
- 申请人： Viva Star Biosciences (Suzhou) Co., Ltd.
- 申请人地址： CN Suzhou
- 专利权人： Viva Star Biosciences (Suzhou) Co., Ltd.
- 当前专利权人： Viva Star Biosciences (Suzhou) Co., Ltd.
- 当前专利权人地址： CN Suzhou
- 优先权： WO TCN2021078597 2021.03.02
- 国际申请： PCT/US2022/018328 2022.03.01
- 进入国家日期： 2023-09-01
- 主分类号： C07D471/14
- IPC分类号： C07D471/14 ; C07D487/04
摘要：
This application relates to novel heterotricyclic compounds and analogues, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating a disease associated with mammalian RAS (Rat sarcoma virus) family proteins.
信息查询
